Neurology in Indiana

Lafayette Instrument Company is a 75+ year-old manufacturer of data acquisition and measurement instrumentation serving research, education, medicine, physical therapy, rehabilitation, security, and law enforcement sectors. The company operates through multiple specialized divisions: Polygraph (credibility assessment systems for government, military, and private examiners); Life Science (neuroscience solutions including behavioral cognitive systems, operant conditioning, exercise activity monitoring, and tissue sectioning equipment); Human Evaluation (motor and functional assessment tools used in occupational medicine, rehabilitation, temporary staffing, and education for 70+ years); and Clegg Impact Testing (surface compaction scanning for soil, artificial turf, and road beds). Lafayette also owns Campden Instruments (translational neuroscience, behavioral cognition, tissue slicing), Aurora Scientific (muscle physiology, neuroscience, materials science research instruments), Actimetrics (automated animal behavioral testing systems), ALZET (osmotic pump drug delivery systems since 1977), and Limestone Technologies (polygraph and credibility assessment software). The company holds CE MDR (Medical Device Regulation) approval for evaluation products and engages in custom fabrication. Manufacturing and service capabilities span design, engineering, and support across multiple research and clinical disciplines.

NeurAxis, Inc. is a medical device company specializing in neuromodulation therapies for chronic and debilitating conditions, particularly disorders of the gut-brain interaction (DGBI). The company manufactures IB-Stim, an FDA-cleared, wearable percutaneous electrical nerve field stimulation (PENFS) device worn behind the ear for treating functional abdominal pain associated with irritable bowel syndrome (IBS) and functional dyspepsia (FD), including FD-related nausea symptoms. IB-Stim is indicated for patients 8 years and older and represents a drug-free, non-surgical alternative. The company has secured multiple payer coverage policies, Veterans Affairs Federal Supply Schedule contracts, and established permanent reimbursement pathways through AMA Category I CPT codes. NeurAxis is committed to improving patient outcomes and reducing suffering through innovation in neuromodulation technology.

Surestep, LLC is a pediatric orthotic manufacturer specializing in custom-made braces and orthotic devices for children from infancy through development. The company designs and fabricates ankle-foot orthoses (AFOs), supra-malleolar orthoses (SMOs), cranial remolding helmets, and related lower-extremity support devices. Their product portfolio includes conventional thermoplastic devices and advanced 3D-printed solutions, with recent product innovations including SMO3D (a lightweight, flexible 3D-printed SMO) and Sprout3D (a cranial remolding helmet with demonstrated clinical superiority in head-shape correction). Surestep emphasizes rapid manufacturing turnaround—AFOs in 10–14 business days, SMOs in 4–8 days depending on customization method, and Sprout3D in 7–10 days—enabling quick delivery to pediatric physical therapists, orthopedists, and rehabilitation centers. The company markets its devices for children with balance disorders, gait dysfunction, hypotonia, plagiocephaly, and other developmental orthopedic needs. All devices are custom-engineered for comfort and growth accommodation. Surestep maintains a clinical focus, citing peer-reviewed research (Hanger Institute study) demonstrating superior outcomes with 3D-printed cranial devices. The company serves pediatric rehabilitation, orthopedic, and developmental medicine markets across the US.

SOPHYSA is a French medical device manufacturer with 50 years of expertise in cerebrospinal fluid (CSF) management and neuromonitoring solutions. Headquartered in Orsay, France with manufacturing and R&D in Besançon, the company serves neurosurgery and neurocritical care specialties globally, including a US subsidiary in Crown Point, Indiana. SOPHYSA manufactures implantable and external drainage systems for hydrocephalus management, intracranial pressure (ICP) monitoring devices, and access ports for neurological applications. Core product lines include adjustable CSF shunting valves (Polaris®, Sophy® Mini SM8, Sophy® Mini SM1), anti-siphon devices (SiphonX®), external ventricular drainage systems and catheters, ICP/temperature monitoring catheters (Pressio® line), implantable access ports (Soph-A-Port®), and associated accessories and reservoirs. The Pressio® 2 system provides integrated intracranial pressure and temperature monitoring for critical care settings. All products are designed for MRI compatibility where applicable. The company serves hospitals, neurosurgical centers, and critical care facilities across multiple continents. Manufacturing capabilities include precision medical device fabrication with quality systems and regulatory compliance in multiple markets.

Plasticity Neurorehabilitation designs and manufactures neurorehabilitation devices focused on neuroplasticity and neuromodulation therapy. The company's primary product, Polyform-1h, is a hand rehabilitation device specifically engineered for neuromuscular re-education and network retraining following neurological injury or other conditions that compromise hand function. The device targets enhancement of functional performance and motor recovery through intelligently designed recovery tools. Founded by Luke K Barr, MD, the company positions itself within a paradigm-shifting approach to rehabilitation challenges. Products are sold direct-to-consumer via their e-commerce platform. The company serves individuals recovering from neurological injuries, disabled veterans, and others seeking improved hand function and neurological recovery.